Gerard Zitnik
Director, Worldwide Medical Neuroscience Bristol Myers Squibb
Gerard Zitnik, PhD, MBA is director worldwide medical neuroscience at Bristol Myers Squibb. His previous industry experience has included Karuna Therapeutics, Idorsia Pharmaceuticals, and Otsuka Pharmaceutical. He received his PhD in neuroscience from Drexel University College of Medicine and continued his academic research as T32 fellow in neuropsychopharmacology at the University of Pennsylvania/Children’s Hospital of Philadelphia. He was awarded a science and technology Policy Fellowship from the American Association for the Advance of Science (AAAS), working in the US Department of Justice. Additionally, he previously served as an adjunct professor of Psychology at LaSalle University.
Seminars
- Insights from long‑term and post‑approval data on real‑world use and safety in schizophrenia
- Ongoing efforts to clarify muscarinic mechanisms and their impact on cognition, negative symptoms, and functional outcomes
- Scientific rationale and development considerations for expanding muscarinic therapies into bipolar disorder and Alzheimer’s disease
